| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
12,959 |
12,506 |
$2.29M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,777 |
4,582 |
$1.31M |
| 80053 |
Comprehensive metabolic panel |
4,462 |
4,012 |
$150K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,094 |
7,212 |
$92K |
| 71045 |
Radiologic examination, chest; single view |
586 |
566 |
$45K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
588 |
559 |
$42K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
881 |
692 |
$35K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
309 |
302 |
$33K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
97 |
93 |
$31K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
275 |
268 |
$24K |
| 36415 |
Collection of venous blood by venipuncture |
7,478 |
6,795 |
$18K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
878 |
810 |
$18K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
287 |
276 |
$15K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
232 |
210 |
$11K |
| 86140 |
|
1,249 |
1,168 |
$10K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
178 |
159 |
$10K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
244 |
220 |
$8K |
| 81001 |
|
783 |
739 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
204 |
190 |
$5K |
| 85027 |
|
217 |
209 |
$5K |
| J2704 |
Injection, propofol, 10 mg |
719 |
382 |
$5K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
75 |
36 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
275 |
150 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
55 |
52 |
$3K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
50 |
47 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
114 |
113 |
$2K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
497 |
421 |
$2K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
52 |
31 |
$1K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
295 |
286 |
$1K |
| 82248 |
|
166 |
158 |
$966.56 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
186 |
175 |
$811.40 |
| 81003 |
|
110 |
107 |
$570.32 |
| 36591 |
|
15 |
12 |
$544.38 |
| 83690 |
|
78 |
76 |
$526.14 |
| 83735 |
|
79 |
76 |
$494.18 |
| J7050 |
Infusion, normal saline solution, 250 cc |
244 |
105 |
$484.15 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
103 |
99 |
$405.24 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
28 |
26 |
$395.42 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
24 |
24 |
$319.44 |
| 84484 |
|
20 |
12 |
$264.70 |
| 85610 |
|
31 |
27 |
$261.63 |
| 81025 |
|
24 |
24 |
$231.59 |
| 87081 |
|
24 |
24 |
$179.52 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
52 |
50 |
$163.81 |
| 85379 |
|
14 |
12 |
$147.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
27 |
27 |
$141.14 |
| 84703 |
|
13 |
13 |
$126.36 |
| 83605 |
|
12 |
12 |
$92.55 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
22 |
12 |
$91.97 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
16 |
13 |
$55.04 |
| 84443 |
Thyroid stimulating hormone (TSH) |
13 |
13 |
$49.78 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
64 |
59 |
$44.53 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
720 |
505 |
$0.03 |